SCHEMBL28072214

SCHEMBL28072214

COc1ccc(CS(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2Oc2ccccc2)cc1

nearest known ligand 0.82

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 1/20 0.65
▸ BCL2L1 Q07817 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1958254 0.90 BCL2 (0.71) BCL2BCL2L1
SCHEMBL2996436 0.85 BCL2 (0.74) BCL2BCL2L1
SCHEMBL1742388 0.84 BCL2 (0.65) BCL2BCL2L1
SCHEMBL28072124 0.84 BCL2 (0.68) BCL2BCL2L1
SCHEMBL1958426 0.83 BCL2 (0.73) BCL2BCL2L1
SCHEMBL1955301 0.83 BCL2 (0.62) BCL2BCL2L1
SCHEMBL1744765 0.82 BCL2 (0.69) BCL2BCL2L1
SCHEMBL1956361 0.82 BCL2 (0.57) BCL2BCL2L1
SCHEMBL1956951 0.81 BCL2 (0.61) BCL2BCL2L1
SCHEMBL1742180 0.81 BCL2 (0.63) BCL2BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102307872-B BCL-2-selectively apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE 公司 2016-06-15 — — CN disclosed
Send feedback